-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, RQYV1bui7SrncPljHoUo+pvGJLPCJ2fA2Px9z1VPMi13WeDXPHzqom8g5FRcwiiE hgyLkCwlXBur9ORLSVSBsA== 0001442643-10-000077.txt : 20101216 0001442643-10-000077.hdr.sgml : 20101216 20101216113531 ACCESSION NUMBER: 0001442643-10-000077 CONFORMED SUBMISSION TYPE: SC TO-I/A PUBLIC DOCUMENT COUNT: 3 FILED AS OF DATE: 20101216 DATE AS OF CHANGE: 20101216 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE INC CENTRAL INDEX KEY: 0000353230 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 311001351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-I/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-33074 FILM NUMBER: 101255421 BUSINESS ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 6063923300 MAIL ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: OMNICARE INC CENTRAL INDEX KEY: 0000353230 STANDARD INDUSTRIAL CLASSIFICATION: RETAIL-DRUG STORES AND PROPRIETARY STORES [5912] IRS NUMBER: 311001351 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC TO-I/A BUSINESS ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 BUSINESS PHONE: 6063923300 MAIL ADDRESS: STREET 1: 100 E RIVERCENTER BLVD STREET 2: STE 1600 CITY: COVINGTON STATE: KY ZIP: 41101 SC TO-I/A 1 formtoa312-2010.htm SCHEDULE TO/A formtoa312-2010.htm
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
SCHEDULE TO/A
(Rule 14d-100)
TENDER OFFER STATEMENT UNDER SECTION 14(d)(1) OR 13(e)(1)
OF THE SECURITIES EXCHANGE ACT OF 1934
 
(Amendment No. 3)
 
OMNICARE, INC.
(Name of Subject Company (Issuer))

OMNICARE, INC. (Issuer)
(Names of Filing Persons (Identifying Status as Offeror, Issuer or Other Person))

3.25% Convertible Senior Debentures due 2035
(Title of Class of Securities)


681904AL2
(CUSIP Number of Class of Securities)


John L. Workman
Executive Vice President and Chief Financial Officer
100 East RiverCenter Boulevard
Covington, Kentucky 41011
(859) 392-3300
(Name, address and telephone numbers of person authorized to receive notices
and communications on behalf of Filing Persons)

Copies to:
Morton A. Pierce, Esq.
Michelle B. Rutta, Esq.
1301 Avenue of the Americas
New York, New York 10019
Phone: (212) 259-8000
CALCULATION OF FILING FEE

Transaction Valuation*
 
Amount of Filing Fee**
$498,750,000
 
$35,561
*
Determined pursuant to Rule 0-11(b)(l) of the Securities Exchange Act of 1934, as amended. Based upon the maximum amount of cash that might be paid for the 3.25% Convertible Senior Debentures due 2035 (the “Debentures”) assuming that $525,000,000 aggregate principal amount of outstanding Debentures are purchased at a price of $950 per $1,000 principal amount.
 
**
The amount of the filing fee equals $71.30 per $1,000,000 of the value of the transaction.
 
 x
Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing.
 
 
Amount Previously Paid:
$35,561
 
Filing Party:
 
Omnicare, Inc.
 
Form or Registration No.:
Schedule TO-I
 
Date Filed:
 
November 17, 2010
 
o  Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.
 
 
 
 
 
Check the appropriate boxes below to designate any transactions to which the statement relates:
o  third-party tender offer subject to Rule 14d-1.
x  issuer tender offer subject to Rule 13e-4.
o  going-private transaction subject to Rule 13e-3.
o  amendment to Schedule 13D under Rule 13d-2.
Check the following box if the filing is a final amendment reporting the results of the tender offer:

 
 
 

INTRODUCTORY STATEMENT
 
This Amendment No. 3 (“Amendment No. 3”) amends and supplements the Tender Offer Statement on Schedule TO (as amended and restated, the “Schedule TO”) originally filed with the United States Securities and Exchange Commission (the “SEC”) on November 17, 2010 by Omnicare, Inc. (“Omnicare” or the “Company”), as amended by Amendment No. 1 filed on December 7, 2010 and Amendment No. 2 filed on December 9, 2010, in connection with its offer to purchase for cash, on the terms and subject to the conditions set forth in the Offer to Purchase, dated November 17, 2010 (the “Offer to Purchase”), and related Letter of Transmittal (the “Letter of Transmittal” and, together with the Offer to Purchase, the “Offer”), on a pro rata basis, up to $525,000,000 aggregate principal amount of Omnicare’s outstanding 3.25% Convertible Senior Debentures due 2035 (the “Debentures”).
 
Only those items amended are reported in this Amendment No. 3. Except as specifically provided herein, the information contained in the Schedule TO remains unchanged and this Amendment No. 3 does not modify any of the information previously reported on Schedule TO. You should read this Amendment No. 3 together with the Schedule TO, the Offer to Purchase and the related Letter of Transmittal.
 
Item 4.  Terms of the Transaction.
 
(a)  
Material Terms.
 
 
(1)
Tender Offers.
 
The information set forth in the Offer to Purchase is amended and supplemented by the following information:
 
The Offer expired at 11:59 p.m. New York City time, on December 15, 2010, which we refer to as the Expiration Date. The Company has been advised by D.F. King & Co., Inc., as Information Agent and Depositary, that, pursuant to the terms of the Offer, Debentures with an aggregate principal amount of $748,226,000 were validly tendered and not withdrawn prior to the Expiration Date. The Company has accepted for purchase $525,000,000 aggregate principal amount of the Debentures validly tendered and not withdrawn at a purchase price of $950 per $1,000 principal amount of Debentures, plus accrued and unpaid interest through, but excluding, the date of purchase. The aggregate consideration (including accrued and unpaid interest) for the accepted Debentures of approximately $498.8 million will be delivered promptly by The Depository Trust Com pany to the tendering holders on a pro rata basis, based on the aggregate principal amount of Debentures validly tendered and not withdrawn in the Offer. After giving effect to the purchase pursuant to the Offer, $452,500,000 aggregate principal amount of the Debentures remains outstanding. The full text of the Company’s press release, dated December 16, 2010, announcing the expiration and results of the Offer, is filed as Exhibit (a)(5)(B) hereto and is incorporated herein by reference.
 
Item 12.  Exhibits.
 
Item 12 is hereby amended and supplemented to add the following:

Exhibit
Number                                                                 Description of Document
 
(a)(5)(B)
Press Release Regarding Results of Offer, dated December 16, 2010.

 
 
 

SIGNATURE
 
After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
 



Omnicare, Inc

By: /s/    John L. Workman                                                                                                     
Name:  John L. Workman
Title:    Executive Vice President and Chief Financial Officer


Dated:           December 16, 2010

 

 
 
 

INDEX TO EXHIBITS
 
     
Exhibit Number
 
Description of Document
(a)(1)(A)*
 
Offer to Purchase, dated November 17, 2010.
 
(a)(1)(B)*
 
Form of Letter of Transmittal, including IRS Form W-9.
 
(a)(5)*
 
Press Release Regarding Offer, dated November 17, 2010.
 
(a)(5)(B)**
  
Press Release Regarding Results of Offer, dated December 16, 2010.
 
(b)
 
None.
 
(d)(1)
 
Indenture, dated as of December 15, 2005, by and among the Company, Omnicare Purchasing Company, LP, as guarantor and the Trustee (including the Form of Convertible Debenture), is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed December 16, 2005.
 
(d)(2)
 
Restated Certificate of Incorporation of Omnicare, Inc., as amended, is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2002, filed with the SEC on March 27, 2003.
 
(d)(3)
 
Third Amended and Restated Bylaws of Omnicare, Inc., is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed with the SEC on December 23, 2008.
 
(d)(4)
 
Annual Incentive Plan for Senior Executive Officers is hereby incorporated by reference from Appendix A of the Definitive Proxy Statement on Schedule 14A filed with the SEC on April 21, 2009.
 
(d)(5)
 
1992 Long-Term Stock Incentive Plan is hereby incorporated by reference from Appendix A of the Definitive Proxy Statement on Schedule 14A filed with the SEC on April 10, 2002.
 
(d)(6)
 
1995 Premium-Priced Stock Option Plan is hereby incorporated by reference from Appendix A of the Definitive Proxy Statement on Schedule 14A filed with the SEC on April 10, 1995.
 
(d)(7)
 
1998 Long-Term Employee Incentive Plan is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 1998 filed with the SEC on March 30, 1999.
 
(d)(8)
 
Amendment to 1998 Long-Term Employee Incentive Plan, effective November 26, 2002, is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2002 filed with the SEC on March 27, 2003.
 
(d)(9)
 
Director Stock Plan for Members of the Compensation and Incentive Committee is hereby incorporated by reference from the Registration Statement on Form S-8 filed with the SEC on December 14, 2001.
 
(d)(10)
 
Director Compensation Program Update is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed on May 20, 2005.
 
(d)(11)
 
Omnicare, Inc. 2004 Stock and Incentive Plan is hereby incorporated by reference from Appendix B of the Company's Definitive Proxy Statement on Schedule 14A filed with the SEC on April 21, 2009.
 
(d)(12)
 
Amended and Restated Omnicare, Inc. Excess Benefit Plan is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on February 26, 2009.
 
(d)(13)
 
Form of Stock Option Award Letter is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed on December 1, 2004.
 
 
 
 
 
 
(d)(14)
 
Employment Agreement with John L. Workman, dated as of October 21, 2009 is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2009 filed with the SEC on February 25, 2010.
 
(d)(15)
 
Separation Agreement, effective as of July 31, 2010, among Omnicare, Inc. and Joel F. Gemunder is hereby incorporated by reference from Omnicare’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, filed with the SEC on October 28, 2010.
 
(d)(16)
  
Separation Agreement, effective as of July 31, 2010, among Omnicare, Inc. and Cheryl D. Hodges is hereby incorporated by reference from Omnicare’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, filed with the SEC on October 28, 2010.
 
(d)(17)
 
Employment Agreement with James D. Shelton, dated September 17, 2010, is hereby incorporated by reference from Omnicare’s Quarterly Report on Form 10-Q for the quarter ended September 30, 2010, filed with the SEC on October 28, 2010.
 
(d)(18)
 
Form of Restricted Stock Award Letter (Officers) is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year December 31, 2009, filed with the SEC on February 25, 2010.
 
(d)(19)
 
Form of Restricted Stock Award Letter (Employees Other Than Officers) is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2009, filed with the SEC on February 25, 2010.
 
(d)(20)
 
Employment Agreement with Jeffrey M. Stamps, dated as of June 1, 1999, is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on February 26, 2009.
 
(d)(21)
 
Amendment to Employment Agreement with  Jeffrey M. Stamps, dated as of December 29, 2008, is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2008, filed with the SEC on February 26, 2009.
 
(d)(22)
 
Amendment to Employment Agreement between Jeffrey M. Stamps and Omnicare, Inc., dated April 11, 2009, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed April 16, 2009.
 
(d)(23)
 
Separation and Consulting Agreement, dated June 29, 2010, among Omnicare, Inc., Omnicare Management Company, MMD Professional Services, LLC and Patrick E. Keefe, is hereby incorporated by reference from Omnicare’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2010, filed with the SEC on August 5, 2010.
 
(d)(24)
 
Summary of Non-Employee Director Compensation is hereby incorporated by reference from Omnicare’s Annual Report on Form 10-K for the year ended December 31, 2004 filed with the SEC on March 16, 2005.
 
(d)(25)
 
Letter Agreement, dated February 21, 2008, by and among Omnicare, Inc., ValueAct Capital Master Fund, L.P. and ValueAct Capital Master Fund III, L.P., is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed on May 20, 2005.
 
(d)(26)
 
Subordinated Debt Securities Indenture, dated as of June 13, 2003, between Omnicare, Inc. and SunTrust Bank, as Trustee, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed June 16, 2003.
 
(d)(27)
 
First Supplemental Indenture, dated as of June 13, 2003, between Omnicare, Inc. and SunTrust Bank, as Trustee, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed June 16, 2003.
 
 
 
 
 
 
(d)(28)
 
Second Supplemental Indenture, dated as of June 13, 2003, between Omnicare, Inc. and SunTrust Bank, as Trustee, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed June 16, 2003.
 
(d)(29)
 
Third Supplemental Indenture, dated as of March 8, 2005, between Omnicare, Inc. & SunTrust Bank, as Trustee, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed March 9, 2005.
 
(d)(30)
 
Fourth Supplemental Indenture, dated as of December 15, 2005, by and among the Company, the guarantors named therein and the Trustee (including the Form of 2013 Note), is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed December 16, 2005.
 
(d)(31)
 
Fifth Supplemental Indenture, dated as of December 15, 2005, by and among the Company, the guarantors named therein and the Trustee (including the Form of 2015 Note), is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed December 16, 2005.
 
(d)(32)
 
Guarantee Agreement of Omnicare, Inc. relating to the Trust Preferred Income Equity Redeemable Securities of Omnicare Capital Trust I, dated as of June 13, 2003, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed June 16, 2003.
 
(d)(33)
 
Amended and Restated Trust Agreement of Omnicare Capital Trust II, dated as of March 8, 2005, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed March 9, 2005.
 
(d)(34)
 
Guarantee Agreement of Omnicare, Inc. relating to the Series B 4.00% Trust Preferred Income Equity Redeemable Securities of Omnicare Capital Trust II, dated as of March 8, 2005, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed March 9, 2005.
 
(d)(35)
 
Sixth Supplemental Indenture, dated as of May 18, 2010, by and among the Company, the Guarantors named therein and the Trustee (including the form of 7.75% Senior Subordinated Note due 2020), is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed May 21, 2010.
 
(d)(36)
  
Second Supplement to the Fourth Supplemental Indenture, dated as of May 18, 2010, by and between the Company and the Trustee, is hereby incorporated by reference from Omnicare’s Current Report on Form 8-K filed May 21, 2010.
 
(d)(37)
  
Seventh Supplemental Indenture governing the 3.75% Convertible Senior Subordinated Notes due 2025, including the form of 3.75% Convertible Senior Subordinated Notes due 2025, dated December 7, 2010, by and among Omnicare, Inc., the guarantors named therein and U.S. Bank National Association, filed as Exhibit 4.1 to Omnicare’s Current Report on Form 8-K dated December 7, 2010, is hereby incorporated by reference.
 
(g)
 
None.
 
(h)
 
None.
 
 
*  Previously filed on Schedule TO
** Filed herewith

 
 
 

EX-99.(A)(5)(B) 2 exhibit-a5b.htm EXHIBIT (A)(5)(B) exhibit-a5b.htm

 
news release
                                                                         CONTACT:
                                      Patrick C. Lee
                                      (859) 392-3444
                                      patrick.lee@omnicare.com


OMNICARE ANNOUNCES RESULTS OF TENDER OFFER FOR ITS
3.25% CONVERTIBLE SENIOR DEBENTURES DUE 2035
 
COVINGTON, Ky., December 16, 2010 – Omnicare, Inc. (NYSE:OCR), announced today the expiration and final results of its previously announced offer to purchase for cash, on a pro rata basis, up to $525,000,000 aggregate principal amount of its 3.25% Convertible Senior Debentures due 2035 (the “debentures”), at a purchase price equal to $950 per $1,000 of the principal amount of such debentures, plus accrued and unpaid interest thereon.
 
Pursuant to the offer, $748,226,000 aggregate principal amount of the debentures were validly tendered and not withdrawn and Omnicare accepted for payment $525,000,000 aggregate principal amount of such debentures. Payment of the aggregate consideration of approximately $498.8 million (including accrued and unpaid interest) will be made on the validly tendered debentures in accordance with the terms of the tender offer. After giving effect to the purchase of the tendered debentures, $452,500,000 aggregate principal amount of the debentures remains outstanding. Barclays Capital Inc. acted as Dealer Manager for the tender offer.
 
This release is for information purposes only and does not constitute an offer to purchase nor a solicitation for acceptance of the tender offer described above. The tender offer was made solely by means of the tender offer documents, including the Offer to Purchase and the related Letter of Transmittal that Omnicare previously filed with the SEC as exhibits to its Schedule TO on November 17, 2010, as amended by Amendment No. 1 to its Schedule TO filed on December 7, 2010 and Amendment No. 2 to its Schedule TO filed on December 9, 2010. The tender offer was not made to holders in any jurisdiction in which the making or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.
 
About Omnicare, Inc.
 
Omnicare, Inc., a Fortune 500 company based in Covington, Kentucky, is a leading provider of pharmaceutical care for the elderly.  Omnicare serves residents in long-term
 


Omnicare, Inc. · 100 East RiverCenter Boulevard · Covington, Kentucky 41011 · 859/392-3300 · 859/392-3360 Fax
 
 
 

 
care facilities, chronic care and other settings comprising approximately 1.4 million beds in 47 states, the District of Columbia and Canada.  Omnicare is the largest U.S. provider of professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other institutional healthcare providers as well as for hospice patients in homecare and other settings.  Omnicare's pharmacy services also include distribution and patient assistance services for specialty pharmaceuticals.  Omnicare offers clinical research services for the pharmaceutical and biotechnology industries in 32 countries worldwide.
 
Forward-Looking Statements
 
In addition to historical information, this press release contains certain statements that constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements are made on the basis of management’s views and assumptions regarding business performance as of the time the statements are made, and management does not undertake any obligation to update these statements. These forward-looking statements include, but are not limited to, all statements regarding the intent, belief or current expectations regarding the matters discussed or incorporated by reference in this document (including statements as to “beliefs,” “expectations,” “anticipations,” “intentions” or similar words) a nd all statements which are not statements of historical fact. These forward-looking statements, together with other statements that are not historical, involve known and unknown risks, uncertainties, contingencies and other factors that could cause results, performance or achievements to differ materially from those stated. Such risks, uncertainties, contingencies and other factors, many of which are beyond the control of the Company, include, but are not limited to: overall economic, financial, political and business conditions; and other risks and uncertainties described in the Company’s reports and filings with the Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize or should underlying assumptions prove incorrect, the Company’s actual results, performance or achievements could differ materially from those expressed in, or implied by, such forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking state ments, which speak only as of the date hereof. Except as otherwise required by law, the Company does not undertake any obligation to publicly release any revisions to these forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.

###

 
 
 

GRAPHIC 3 ocrlogo.jpg GRAPHIC begin 644 ocrlogo.jpg M_]C_X``02D9)1@`!`0$`8`!@``#_X0!F17AI9@``24DJ``@````$`!H!!0`! M````/@```!L!!0`!````1@```"@!`P`!`````@```#$!`@`0````3@`````` M``!@`````0```&`````!````4&%I;G0N3D54('8U+C`P`/_;`$,``@$!`0$! M`@$!`0("`@("!`,"`@("!00$`P0&!08&!@4&!@8'"0@&!PD'!@8("P@)"@H* M"@H&"`L,"PH,"0H*"O_;`$,!`@("`@("!0,#!0H'!@<*"@H*"@H*"@H*"@H* M"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"@H*"O_``!$(`%@! M`P,!(@`"$0$#$0'_Q``?```!!0$!`0$!`0```````````0(#!`4&!P@)"@O_ MQ`"U$``"`0,#`@0#!04$!````7T!`@,`!!$%$B$Q008346$'(G$4,H&1H0@C M0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I*C0U-CH.$A8:'B(F*DI.4E9:7F)F:HJ.DI::GJ*FJ MLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7V-G:X>+CY.7FY^CIZO'R\_3U]O?X M^?K_Q``?`0`#`0$!`0$!`0$!`````````0(#!`4&!P@)"@O_Q`"U$0`"`0($ M!`,$!P4$!``!`G<``0(#$00%(3$&$D%1!V%Q$R(R@0@40I&AL<$)(S-2\!5B M7J"@X2%AH>(B8J2DY25EI>8F9JBHZ2EIJ>HJ:JRL[2UMK>X MN;K"P\3%QL?(RKR\_3U]O?X^?K_V@`,`P$` M`A$#$0`_`/W\HHHH`****`"BO.OBS^UI^SG\#/%FF>`_BG\6-,TG6]9F@CT[ M29&>2XE\Z3RXVV1JQ5"^1O;"\'G@UYY^U=_P4R^`O['GQ4TKX/\`Q.\*^+KW M5=9L8;NSDT/3K>6`QRS/$,M+<1G(:-L@`X&.N:]/"Y-FN-J0A0HRDYIN.CU2 MW:ONEUL>3C,^R;+ZVD&4E\ML.%/J0.>.M85LOQ^&H0K5:4HPFKQDT[ M27D]F;X?-,MQ>(J8>C6C*I3=I14DY1?FMU!S7RK_`,%4?BA^U+X+ M_9_\/_M%?LA_$:`^'-(O(=1\2)ID"S/>V3%'AG649W6P/$BKC3J)>.VDTS7HFLTU"0J)$>SF)&Z1''R]&+)E0P& M:^.=*^.__#O#XL^+?^";GQ!^/RZG\/=?TJ6WT3Q4MLES=>#);R-MBW$+J4=` M'5I(QD8<2*%W,E?>\,Y'66(C6=)RK0M4]E.%XU*+2O*+L[R5[I6[:?\;OB ME^S7\4[.W8MXH\'Z?'O7GOPQ^'/C30K'XA?\$P? MC(D37NM@:_\`#"_24/;3:S#&7MWMI/NM#?6X,2L.K&,8#$@>BZ!^S!^T!\6/ MV:_@I+KO@"[T[5O@MXRN;;Q59ZT5M+F#2[JYL[RUD\J7:S#:[J``3\IXK]-P M]'`9++#1=5.-&53D;:UI5H2<&GU7.E#_`!>J/R+%8C,L_CBY*BU.O"E[2*B] M*^'J1C4371N#=3_#Z2+?_!1#X/ZG^T9_P68\,_!N[:*>TU.#1XIDB)8Q6*(T MUP'&."$$S>F&7GG%>??M!>-?VB?VG?\`@K!J&A?!C5-7\(ZQI>LC0M%N8Y)+ M1M'TRRR'GE*D%(@JRSLI."'(P<@5]2:[HGB_X%?MV?M#_M\?%CPC,;/P3X,@ M'@V`.LHNVN(EMX''EDE`?L\BMNVE5F)(QS7E?@#X>^!_V8/V'_&7[1?[5;ZI M?_$_]H&UGM]"T?3K@PZI+!I52G4=KV:A!1<[M=FU=G?FV52KXS$NUU*I4-?C]=?LT^(/$_AFVL_%3Q M!I_]H>"_#&LV9;3-!BW%5O+S/%S%9-]WJ+P!1J-G*Y\N8[0$#JV8V`QP$/4(I-.,;TQ4(\G-JO=O:_E?I?NSPE27/R:/ MWK7Y7T=NMM['R+\?/VNO^"?7[8GPOU?P7\4/!G]G^.[/1YG\.Z!\0;,Z'?PW MI1O*BCO7(CAS)@$&4`]P:_/?QWK7Q(-G8_#/]N'X2ZY>%42V\.^/+:V#:K;H M!A$2XYBU2`=!&[E@"?+E0<'[X_X*6_';X-_'O]F__A"?B_X*^)WPNM+C6K8P M>*?$WPL>:-9$#N+<$3J5+8)R&Z(1@YKX=^#)^"WPJ\:::OA3_@HYJ>GZ(MZ) M;R.R\#ZGO##E'6U*20R.'"_>/')!]?WS@^C2P^53J0I5(ZMJ#52IRM+>G4A" MT4^L>63=K2;6A_-/'5>MBLYA3J5:4_=2E.+I4^=-[5*52?-)QM[L^:*C>\4G MJ?67[)WPM^'VB?`K3H?B'X\T?XE^&M-L+C2[OQ19Z4\/B#X67+3F2)MDP\^. MV1UCD+%5-O(K,H:%G(^I-%B\9^.;;4;C5-*$^L:AHUGI7BA]/A+0RWUA=QO% M=1XX\NXMKLS(?[BA>JFOF'P-\2S\5?B1HVKZ5\;-,\UFL[J/&,Q7$9B;G.W.1^BGAKPWHWA#0;7PUX>T^&TLK.$1V] MO;Q!$11V51PH]A@#H,"OSSBG%UL/B%.JFYS;>J<;:IO1QAUM=\D.9I-JZ;G^ MH\&X*ABL*Z=%I0@E&Z:DWI9:J4UM>R]I/E4FE)IJ,/G;XJ7>FZK=ZUX9\;K< MV^CZYX@_M3QM'';.UQ>:?$XM-.T>*,#=))>M;;C&O)B\T''F`UP'C1?"'@S] MH)_VC?B#\,KWQ]\:;ZUB@^'OP?T.[6[/A2R5,)-.W,5HSTT_'-46QL8R%+F":^8%WD=44$1Y9F4!9`"`/ES]D'_@I;\7=,_:H^'_ARQTK2 M?"'PZ/B!+.Y\%>#])%M9&*X!@,LI^:6YD3>LA>1W.4R,9KZIG\-_\$J;;5H_ M$?QO\1_$WX@ZK$3_`,3#X@Z5XCO6!/4^6+=(@/;;@#CI7R'JO_!2O]JKX9ZG M>:9\#?A'X+\`:9'.\=E+X9^&\-L[0`D*S&='NKU/S+B/$8?*,SH8^&+]FW).7LY_6*M1Q: M?[V7[M15K)04G3LO=BK'[=U\$_\`!;S_`(+1:'_P2_\``^F^`?AKH5CK_P`5 M/%=F]QHNGZ@6-II5H&*?;;E5(9P7#+'&"N\HY)`0AONGPYJ#ZMX>L-5D.6N; M**5CC'+(#_6OY=_^#C_Q=XD\4_\`!7OXFV?B"23R]&M](L-,B<\1VPTVVE`7 MV+RR/]7-?@P?\`!/;_`(.9?VR_V>OB?8^"OVU]?N?B M)X&EO!;:S-J-BB:UI`W!6EBE15,Q3DM%*&+8(#(:_6K_`(-]_AIX'^''_!)G MX42^#-.@BD\0:=>#/$%MJ.CZWIT-_I.H6T@,=U;2H)(Y4/=65@1]:?XA\ M7^$_"-K'?>*_%&G:9!-($BFU&]CA1V/107(!/M7\A'[37Q:^).N_##X&MJ'B MC4H?L'PE&GVHCO)$#6\&MZJD7`..$`0>R`=J]?\`C/\`L+?\%'OCE_P3JT'_ M`(*9_&7X@6^M_#OPYI-GH_A[2+_7)'OK#2()ETZ&6*VV>6D7FJH.'\Q\F1@< MEJ!6DEH-02ZC:`Q^8)PX*%,9W9Z8QSFL_P`.>-_!?C`S#PEXOTO5 M#;MB<:=J$<_EGT;8QQ^-?RP_\$]M,_X*4_\`!1+PW)_P2]_9X^/%S9^#56?Q M%J6G:WK,L%C:01B.)E>2-'E\@O)'BW4%#(V\KG+#RGPOXI_::_X)6_MP3V^E M^(YM"\5,C###*_(!Z`!3M:9` M1U!85FZYXY\%>&+ZWTSQ+XPTO3KF[_X];>^U".%YN5`5SC&<<5I?\%*O^";W_!1? MX-_"[P]_P4#_`&T_&=CXC;XE7T)N[L:Y)=7^GW%Q"]Q##<(T:I&#&KX6)F1- MNSY<`4!R>9^]G_!:GP%^W]\1OV3M-T/_`()PZOKUGX[3QE:S7DOAWQ#%ILYT MX07`D!EEDC!7>825#9)`..*\Y_X(4?"O_@JY\,[#XDK_`,%/-?\`%5[+>3:9 M_P`(7DM#G)&<#'0U^.,7[97QK^+O_!#CQ%\&O'G MCS5M1;X<_&S0!X=U&YOY&G@L+S3]3/V3?G/?V"/^">'[2GQO\,:K)>^+]1UOPQH'@U]3E::.VO+E-29K@JY(;RXHI9` MI&&9$#9&:`Y78_I&\2^.?!7@Q8W\8>,-+TE93B(ZEJ$<`<^V]AFKVG:EIVKV M4>I:3?PW5O*NZ*>WE#HX]0RD@U_+=_P3Q_X)N_M7_P#!=#XI^//B!XQ_:-EM MY/#L,,VM^+?%S3ZE-"`1'(2=P5`%`4Y`KVW_@GQ^S3_P7._X) M@_M:69\#_L[_`!!UKP-9>)_L/BW1=/1I]'US3UG,E?%CX6:[J0T;1/B5X?O+ MPG`M;368)),^FU6)K\9O^"]G[&G_``4._:8_:,U3Q-X^_:P^%G@7X/VJ1Q>! MO#OC'XI)H\+Q+$GFW$ENZ@2S/+YA+?,0NU1P*_-G]O/]D[]C[]D_0_!TW[,O M_!032?B_XGO`X\4V?AS0Y8+;2I$1")8;O>RR*7+*!P^%#'&<4"44^I_6\[I& M,NX4>I.*KZCK&D:/ITNKZMJMM:VD"[I[JYG5(XQZLS$`#ZU_,C\2/VN_CO\` M'C_@@=I&F?$[XBZOJM]X%_:+@T?2-8NM0D:Z:P?19YT@DD)W2!'9PNXG"E5Z M*,?/?P`TC]O[]M?X>C]BC]G30/%?C/2+'6KCQ/J.@:5*[1M/)%;V_GW3NXC" MH(46/>0`TCXY8T#Y#^O2PU73-4TV+6=,U*"YLYXA+#=03*\2@$ M>_!+9%7]J7]BK]FC]D?X.:'\=_V6/^"K'A'Q]X[T^[@76/#_`(4$UC=VKO\` M\M[&=9"\BQMC)81MM^<8P5H#D/ZM**^"/^#>C_@H]XT_X*"?L:7%C\8]4^W> M//AQJ$6C:]J;MF35+9XMUI>RY/\`K75)4<_Q/`S_`,>!][T$M684444""L#X MF>/HOAEX.N?&,WA'7M=%LT:_V9X9TMKR\E+N$&R)2"P&P:63"K(S%6D3Y0:^2/AG:?M/BP@^,?A#]GGX M2_LY^%;5P8/B'XA\.1K>P*006MVU!IKB>0KNVB)`&/&X9S7Z/^,?B1^T1\0/ M&6H_#/X)?"\Z!8:?<&VU/X@^-K;_`$7./F^P6:L)+T@$8DBC\E=J6ZGC=%%@ M#:69U4?-^K\+YAAJ6%E@ZL81,$ZE64N:RY8TG)T^9]7-Z+5PLC\5XQRO% M5<;''T9U)J*M*HU3HPBXMMRE64%5Y%LE!:O2,^9V.(\0?'.7QKIFH^/_``Y\ M7?'GBSP_H%TG]I?%CXI:K<0:/%=C#)#I6AP.B7-RV-R1RL^"`75$&\?8GP@_ MX*L_`>Z\*K9?M!7MYX.\0Z>/)U.*]LGGCDF6W:X90T"$+,L*J\L6T>4\@CRQ M%?'7C\_$#Q%\._#7[8_Q;\-6>E-?ZA_9?[-WP+TK3E6TCGE($-\\7RJRHS++ MRF9G6+<51T6O*OB/\(/'O@>^NOA?XKT2]N-3\%_#76-8\?WVTS"VUW5+=Y2D M\R[D\P0FT3)8[FC;!-?18G(,FSRC&C7]UQ4U&_/%VDGK%M7G7$TIUF^?2XFEU!;9MTUO:6MT"MRR#RY7AD5#+&W M[M@PS7`?LPEO%/BWPXO@[Q?XF\(Z1JU^4TSXC?##QO<#PX+A4:1;75M(OI2; M)V"*OE!T5V<",,IW5XA\*/V4_P!HCXN^))?"7@WP'K-KJ%WX`L/%%G=2J;.? M2=4LUD@AF`D*O^_DM9HQL!),\;]$!K[Y_9U^%GP]_9X^'2?M'V?AW1_%OAGX MCZ#9O\4=0TS0MC6TZ*P>^6T.X?9MS/\`:;<*&CY^$/A;X@0I$WD3^%M:;2KPD+P6MKW=$)DJP.`R?$8NK1P]1I)N%2,H5% M&WNRBI*4=7+:"2>GO'T/$$LQS+/<+@:-?$THMM1J4Y1G2'X_=*F3P074#VUS"DDH([5^5'[1%\K/YF?^"9/_!Q-\>O^"='[/;?LU7GP:TGQYX?L+J>X M\,/?ZO+93Z69F,DD)94<2PF1F<+A6!=OFP0%^==;/[87_!9;]NO4?$>@^#Y? M$7CWQ_JR/+;:;`ZV>EVRJL:;F.X06L$2JI=SP$Y+,>?Z8OB%_P`$@/\`@F+\ M4O$DWB[QG^Q)X"FU&YD,ES<6>D?8_-<]69;)4\9_&O]FSP+XMU>*T6UCU3Q)X5M M+VX6!2S+&))HV8*"S$+G`+'UK8E^`/P-G^$8^`4WP>\,OX&6V6W'@]M#@.F" M(2>8(_LVWR]H,U)P3\*+OC_N(6%?*?_!:T MY_X*P?')L\?\)Y/S_P``CK^I+X3?LD?LL_`7Q#-XM^"'[.7@?PAJES:&UN-1 M\->%[6RGD@+*QC9X8U8H653M)QE0>U97C/\`8._8D^(WBN^\=_$#]D;X;:WK M>J7!GU+5]5\%65QN?RX_\%@_F_P""D?Q1(Y'] MJ6G3_KPMJ_8+_@YA8?\`#FSX:?-U\8>'L<]?^)5>5^A7B_\`8(_8?^('B.Z\ M8>.OV0OAIK.K7SAKW4]3\$V,\\[!0H+R/$68A5`Y/0`5U_Q*^!/P4^,W@ZV^ M'GQ<^$GAOQ/H-E-'-::+K^BP7=K#)&I1'2*5652JLR@@<`D#K0+FV/Y/?A80 M/^"6'QA0GG_A;W@OC_MQUZO5/V!?V-?B/^VA_P`$QOVC?#7P@T6?5?$W@SQ9 MX5\3Z?HMJI:;4(X8-5AGBC4Q%T8]VPR>2B[]NYL9SC65_:>#K>[&@Z09\M+< M3E.65:_97XT_\$U/V`_VB/%4GCKXT?LB^!->UN=MUSJ]SH$2 M7-P?626,*TA]V)KL_@3^RU^S?^S!HLOA_P#9X^!GA;P9:W&/M*>'=%AM6N". MAD=%#2'_`'B:`K:W)JEI\0;VSU!) MAF:UT^.Y80QVZ.0JQBWV&(<*5*GH$/!W_``3*^%WC M1[BRNS<>-_'7C%Y_-E+Q;8+/:SF-6)661BB(I*#:6&E2Z+^P7^Q/X>^%P^"> MD?LG?#R+PD+Y+UO#S>$K1[62Z1659W1HR'E`=P';+`,1GF@?.C^9/0YHC_P0 MT\06XE7S!^U'I[&/<-P!\/W&#CK@[6_(^E?I)_P9U:1IJ?#CXZ:X+.,7CZWH M<#3[?F\H0WC!<^F6)K]0H?\`@GS^PE;Z#<>%K?\`8W^&*:9=W45S=:Q$ M$TT:NLO]BWXF_LD_\`!1CQMXY\ M3^$+B;P?\0?$D_B/PQJYC?[->+H6-CI^%_>%+J.YE>?YN$'E)D'+ M;2-I_I'^)OPH^&'QI\(W'@'XO_#O1/%&AW7_`!\:1X@TN*[MY#S@F.567(R< M'&1VKQ7PA_P2/_X)E>!/$D7BWPQ^PY\.(;^"7S()IO#D4ZQ/V94E#*I';`XH M#FTU/#?^#?7X3?"72_V:-<_:2^%?[#C?`ZV^)%]:FTTR;QI?:Q)K6G6B2&VO MC]K"F%&>ZN0@4?.H#Y*E#7WY3+6UMK*VCLK*W2&&%`D442!510,!0!P`!QBG MT$MW84444""BBB@#(\?Z_KWA7P3JOB3PMX.N?$.I6-C)-8Z'9W$<4M]*JDK" MKR$*I8\9)P*^?Q^Q'X(^+>A7/QF_X*!VNG^)/$KM'J$MLUY(FE^%;2!O.%C: M@,`8@`?/D;)G.=WRA0/I>O./VL/@%?\`[3OP-U?X)V?Q'OO"\6M&..^U"PME ME>2W#AI("&(^5P-IP1QP<@E3ZV58Z>%JQIQJ>RYI+FJ*_-&/6UM;=6EJ]F[' MB9SEU/&495)TO;\L7RTI?A_JE[/;^%4T#0M)\/V+W$\-O(%MV<)&"QV0L[E@,Y&:X#]I_P"' M*_!C_@C1J?PUFB,,NC_#G3K>Z5EP?M!>W\W(]3(S9^M?<8/-88N="4(J,9UZ M-*G'K&E3DIN_=RE*+D^LDS\[Q^2U,##$0G)RG##UZU6;6DJU6#@K=E",)J,? MLQ:1;^/7Q0T3X$_&+X#?M<^*-;CL/#NNZ#/X4\8:G<.1%'!=VT=[:2.W/"SP M.)?A7\2?$4>IR_P"D,O\`8MV_S7\5 MOM^4BY7%Q'N.T2>><$-Q5\6?";7/VJ?^"('AOPWX:TFYU/7;/P5IUWH]K:Q& M2::XLG"%$49+,T:2(`.3NQ7H7P3_`&;O&'[4'_!-;1?V;_VP_!E_H&LPZ6MA MON&1[JW^S/BSNUY.UQ&$!5L$X<'AJR@LJP5.G4QMIPIU9T*L+V;@I.4:D4GS M7@VU==$H[-WVJ/.LPJU*67WA.K1AB:-1*\54<8PG2DVG&TTD[/JW+=*WSI^T M9_P3B\2>-?B!X0_;;_X)<>*8["#Q3>V]U+!IMZ+9-.:9OFO(L\+""6$T&"4( M8!&!*+^D?@VP\3:5X2TS3?&>OQ:KJ]O811ZGJ<-H($NK@(!)*L8)$89LD*#Q MG% -----END PRIVACY-ENHANCED MESSAGE-----